DE60335490D1 - Spezifisch in postmitotischen dopamin-produzierenden neuronalen vorläuferzellen exprimiertes gen - Google Patents

Spezifisch in postmitotischen dopamin-produzierenden neuronalen vorläuferzellen exprimiertes gen

Info

Publication number
DE60335490D1
DE60335490D1 DE60335490T DE60335490T DE60335490D1 DE 60335490 D1 DE60335490 D1 DE 60335490D1 DE 60335490 T DE60335490 T DE 60335490T DE 60335490 T DE60335490 T DE 60335490T DE 60335490 D1 DE60335490 D1 DE 60335490D1
Authority
DE
Germany
Prior art keywords
precursor cells
dopamin
postmitotic
specifically expressed
neuronal precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60335490T
Other languages
English (en)
Inventor
Yasuko Nakagawa
Yuichi Ono
Yoshimasa Sakamoto
Eri Mizuhara
Tomoya Nakatani
Yoshimi Takai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of DE60335490D1 publication Critical patent/DE60335490D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
DE60335490T 2002-10-22 2003-10-21 Spezifisch in postmitotischen dopamin-produzierenden neuronalen vorläuferzellen exprimiertes gen Expired - Lifetime DE60335490D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002307573 2002-10-22
PCT/JP2003/013420 WO2004038018A1 (ja) 2002-10-22 2003-10-21 分裂停止後のドーパミン産生ニューロン前駆細胞に特異的に発現している遺伝子

Publications (1)

Publication Number Publication Date
DE60335490D1 true DE60335490D1 (de) 2011-02-03

Family

ID=32170942

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60335490T Expired - Lifetime DE60335490D1 (de) 2002-10-22 2003-10-21 Spezifisch in postmitotischen dopamin-produzierenden neuronalen vorläuferzellen exprimiertes gen

Country Status (9)

Country Link
US (3) US7622270B2 (de)
EP (2) EP1795595A1 (de)
JP (1) JP4118877B2 (de)
CN (2) CN1891826B (de)
AT (1) ATE492636T1 (de)
AU (1) AU2003301576A1 (de)
DE (1) DE60335490D1 (de)
SG (1) SG146441A1 (de)
WO (1) WO2004038018A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622270B2 (en) * 2002-10-22 2009-11-24 Eisai R&D Management Co., Ltd. Methods of isolating dopaminergic neuron precursor cells
WO2004065599A1 (ja) 2003-01-24 2004-08-05 Eisai Co., Ltd. Lrp4/Corinドーパミン産生ニューロン増殖前駆細胞マーカー
EP1712638B1 (de) 2003-11-26 2009-06-10 Eisai R&D Management Co., Ltd. Spezifischer Marker Lmx1a für dopaminerge Neuronen
JP4717797B2 (ja) * 2004-07-22 2011-07-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｌｒｐ４／Ｃｏｒｉｎドーパミン産生ニューロン前駆細胞マーカー
EP1666590B1 (de) * 2004-07-22 2015-11-04 Eisai R&D Management Co., Ltd. Lrp4/corin-marker von dopamin produzierenden neuronenvorläuferzellen
JP4618736B2 (ja) * 2004-07-22 2011-01-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｌｒｐ４／Ｃｏｒｉｎドーパミン産生ニューロン前駆細胞マーカー
WO2007021003A1 (ja) 2005-08-18 2007-02-22 Eisai R & D Management Co., Ltd. ドーパミン産生ニューロン増殖前駆細胞マーカーＮａｔｏ３
CA2619736C (en) * 2005-08-18 2012-05-22 Eisai R & D Management Co., Ltd. Dopaminergic neuron proliferative progenitor cell marker msx1/2
US8198081B2 (en) 2006-04-11 2012-06-12 Eisai R&D Management Co., Ltd. Dopaminergic neuron progenitor cell marker 187A5
CA2677996C (en) 2007-02-09 2018-06-12 Eisai R&D Management Co., Ltd. Gaba neuron progenitor cell marker 65b13
CA2726426A1 (en) * 2008-06-04 2009-12-10 The Arizona Board Of Regents, On Behalf Of The University Of Arizona Diffuse large b-cell lymphoma markers and uses therefor
WO2010016533A1 (ja) 2008-08-08 2010-02-11 エーザイ・アール・アンド・ディー・マネジメント株式会社 Neph3(65B13)とE-カドヘリンを用いたプルキンエ前駆細胞の取得方法
US8877449B2 (en) 2008-12-22 2014-11-04 Eisai R&D Management Co., Ltd. Method for obtaining pancreatic progenitor cell using NEPH3
EP3578205A1 (de) 2010-08-06 2019-12-11 ModernaTX, Inc. Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung
CA3162352A1 (en) 2010-10-01 2012-04-05 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
JP6090937B2 (ja) * 2011-07-27 2017-03-08 国立大学法人京都大学 新規ドーパミン産生神経前駆細胞マーカー
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
PT3682905T (pt) 2011-10-03 2022-04-07 Modernatx Inc Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações
LT2791160T (lt) 2011-12-16 2022-06-10 Modernatx, Inc. Modifikuotos mrnr sudėtys
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
CA2868996A1 (en) 2012-04-02 2013-10-10 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
JP2016538829A (ja) 2013-10-03 2016-12-15 モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 低密度リポタンパク質受容体をコードするポリヌクレオチド
CN112522425B (zh) * 2020-12-25 2023-11-28 武汉睿健医药科技有限公司 Dpc细胞鉴定分类用标记物基因、筛选方法及应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
JP2928287B2 (ja) 1988-09-29 1999-08-03 協和醗酵工業株式会社 新規ポリペプチド
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
EP0546026B1 (de) 1990-08-30 2000-08-02 Cargill Incorporated Brassica-öle mit geänderten fettsäuregehalten
US5981165A (en) 1991-07-08 1999-11-09 Neurospheres Holdings Ltd. In vitro induction of dopaminergic cells
WO1993002227A1 (en) 1991-07-15 1993-02-04 Eco-Tec Limited Process and apparatus for treating fluoride containing acid solutions
IT1251435B (it) 1991-09-04 1995-05-09 Sclavo Spa Vettore genetico per la integrazione multipla stabile di sequenze di dna nel genoma dei lieviti kluyveromyces lactis e saccharomyces cerevisiae e plasmidi che lo contengono.
EP0617706B1 (de) 1991-11-25 2001-10-17 Enzon, Inc. Multivalente antigen-bindende proteine
NZ255101A (en) 1992-07-24 1997-08-22 Cell Genesys Inc A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
US5285485A (en) 1993-02-01 1994-02-08 General Electric Company Composite nuclear fuel container and method for producing same
CA2159738A1 (en) 1993-04-13 1994-10-27 Eugene O. Major Use of neuro-derived fetal cell lines for transplantation therapy
US5753491A (en) 1993-04-13 1998-05-19 Us Health Use of neuro-derived fetal cell lines for transplantation therapy
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
US5554381A (en) 1993-08-09 1996-09-10 Cygnus, Inc. Low flux matrix system for delivering potent drugs transdermally
US6294383B1 (en) 1994-11-08 2001-09-25 The Mclean Hospital Corporation Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US6204053B1 (en) 1994-11-08 2001-03-20 Diacrin, Inc. Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US6277372B1 (en) 1994-11-08 2001-08-21 Diacrin, Inc. Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases
JP3699727B2 (ja) 1995-03-13 2005-09-28 ユニヴァーシティ オブ サウス フロリダ 神経変性疾患用の神経回復誘発細胞としてのセルトーリ細胞
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US6653134B2 (en) 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5753505A (en) 1995-07-06 1998-05-19 Emory University Neuronal progenitor cells and uses thereof
US20020127584A1 (en) * 1997-09-18 2002-09-12 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20030032103A1 (en) * 1997-09-18 2003-02-13 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19756864C5 (de) 1997-12-19 2014-07-10 Oliver Brüstle Neurale Vorläuferzellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Therapie von neuralen Defekten
EP1096941B1 (de) 1998-05-07 2005-08-10 University Of South Florida Knochenmarkszellen als quelle von neuronen zur wiederherstellung von gehirn und knochenmark
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
US6913925B1 (en) 1998-08-12 2005-07-05 Signal Pharmaceuticals Llc Human mesencephalon cell lines and methods of use therefor
US6610540B1 (en) 1998-11-18 2003-08-26 California Institute Of Technology Low oxygen culturing of central nervous system progenitor cells
US7217565B2 (en) * 1999-02-12 2007-05-15 Stemcells California, Inc. Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
JP2001184757A (ja) 1999-12-27 2001-07-06 Aiwa Co Ltd テープレコーダ
IL151170A0 (en) * 2000-03-14 2003-04-10 Es Cell Int Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
CA2381065C (en) * 2000-06-01 2007-06-05 Japan Science And Technology Corporation Method for enrichment and/or isolation of dopaminergic neurons
JP2002051775A (ja) 2000-06-01 2002-02-19 Japan Science & Technology Corp ドーパミン作動性ニューロンの濃縮・分離方法
AU2001270058B2 (en) * 2000-06-22 2006-11-02 Biogen Idec Ma Inc. GP354 nucleic acids and polypeptides
US20040241170A1 (en) * 2001-08-24 2004-12-02 Jensen Charlotte Harken Isolation of cells from neural cell populations using antibodies to fa1/dlk1
US7622270B2 (en) 2002-10-22 2009-11-24 Eisai R&D Management Co., Ltd. Methods of isolating dopaminergic neuron precursor cells
WO2004065599A1 (ja) 2003-01-24 2004-08-05 Eisai Co., Ltd. Lrp4/Corinドーパミン産生ニューロン増殖前駆細胞マーカー
EP1712638B1 (de) * 2003-11-26 2009-06-10 Eisai R&D Management Co., Ltd. Spezifischer Marker Lmx1a für dopaminerge Neuronen
CA2677996C (en) 2007-02-09 2018-06-12 Eisai R&D Management Co., Ltd. Gaba neuron progenitor cell marker 65b13

Also Published As

Publication number Publication date
US20060239978A1 (en) 2006-10-26
SG146441A1 (en) 2008-10-30
EP1795595A1 (de) 2007-06-13
US7622270B2 (en) 2009-11-24
JPWO2004038018A1 (ja) 2006-02-23
CN1891826A (zh) 2007-01-10
US20070122882A1 (en) 2007-05-31
CN100572535C (zh) 2009-12-23
US8039224B2 (en) 2011-10-18
US20100203570A1 (en) 2010-08-12
AU2003301576A1 (en) 2004-05-13
CN1891826B (zh) 2011-09-14
JP4118877B2 (ja) 2008-07-16
EP1561814A1 (de) 2005-08-10
EP1561814B1 (de) 2010-12-22
ATE492636T1 (de) 2011-01-15
EP1561814A4 (de) 2005-12-07
WO2004038018A1 (ja) 2004-05-06
CN1729290A (zh) 2006-02-01

Similar Documents

Publication Publication Date Title
DE60335490D1 (de) Spezifisch in postmitotischen dopamin-produzierenden neuronalen vorläuferzellen exprimiertes gen
BRPI0408733A (pt) derivação de neurÈnios dopaminérgicos terminalmente diferenciados de células tronco embriÈnicas humanas
CO6541559A2 (es) Constructor de vector vírico novedoso para síntesis dopa continua optimizada específica de neuronas in vivo
MXPA05012645A (es) Piridopirazinas novedosas y su uso como moduladores de cinasa.
RS20050876A (en) Novel pyridopyrazines and use thereof as kinase m odulators
ECSP066355A (es) Compuestos de 2-(quinoxalin-5-ilsulfonilamino)-benzamida como moduladores de la colecistocinina 2
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
SG148071A1 (en) Purine compounds and use thereof as cannabinoid receptor ligands
DE602006018768D1 (de) Konditionell immortalisierte adulte langzeit-stammzellen und verfahren zur herstellung und verwendung von solchen zellen
EA200601227A1 (ru) Применение ротиготина для лечения или предотвращения гибели дофаминергических нейронов
TW200509892A (en) Novel aminobenzophenone compounds
DE602005010047D1 (de) Nervenwachstumsfaktor sezernierende menschliche therapeutische zellen
ATE466965T1 (de) Kupfer-zink-silizium-legierung, deren verwendung und deren herstellung
GT200200039A (es) Uso de agonistas inversos de gaba a en combinacion con agonistas parciales del receptor de nicotina, estrogenos,moduladores selectivos de estrogenos o vitamina e, para el tratamiento de trastornos cognitivos
UY28733A1 (es) Compuestos quimicos
ATE431446T1 (de) Herstellung vom elektrolytischen wasser
AR033141A1 (es) Produccion de neuronas tirosina hidroxilasa positivas
AR036400A1 (es) Regulacion combinada de la produccion de celulas nerviosas.
ATE433501T1 (de) Spezifischer marker lmx1a für dopaminerge neuronen
CR9395A (es) Compuestos utiles para inhibir chk1
WO2005000233A3 (en) Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
WO2005021704A3 (en) In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders
NZ515891A (en) New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
WO2005118920A3 (en) Methods for generating neuronal cells from human embryonic stem cells and uses thereof
MXPA05003264A (es) Pirroles 3,4-disustituidos y su uso en el tratamiento de enfermedades inflamatorias.